|Articles|April 13, 2020

Contagion Live News Network: Coronavirus Updates for April 13, 2020

This is the COVID-19 update for Monday, April 13, 2020.

Welcome to the Contagion Live News Network. I’m Grant Gallagher and this is the COVID-19 update for Monday, April 13, 2020.

Recently on ContagionLive, we have an interview with advice from Thomas Dilworth, PharmD, for clinicians who are struggling to stay up to date with all the news and published literature about COVID-19 while trying to respond to the pandemic.

We also covered how limited ICU Space Played a Role in COVID-19 Deaths in Wuhan, China.

In US news, New York governor Andrew Cuomo confirmed today that the state has surpassed 10,000 deaths from COVID-19.

Across the United States, there are more than 560,000 cases and 22,000 deaths.

Around the world, there are over 1.8 million cases. There have been more than 117,000 reported deaths.

For other stories relevant to COVID-19 and the latest infectious disease news, visit ContagionLive.com. To track the spread of infectious diseases in the United States and abroad, you can use the Contagion Outbreak Monitor.

For the Contagion Live News Network, I’m Grant Gallagher. Thanks for listening.


Related to this article

New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
REMAP-CAP and the Tamiflu “Pre-Release”: A Set-Up for Disaster
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.